Encephalopathies
Capsida Suspends Gene Therapy Trial After First Patient Death
Capsida Biotherapeutics; gene therapy; CAP-002; clinical trial suspension; STXBP1 encephalopathy; patient death; FDA
Actionable Insights Powered by AI
Capsida Biotherapeutics; gene therapy; CAP-002; clinical trial suspension; STXBP1 encephalopathy; patient death; FDA